Zhuhai announces it has passed the peak of new crown infections, ibuprofen inventory can meet clinical demand, monthly capacity of 2.6 million copies of antigen detection reagents
“At present, major cities in China are passing or have passed the peak of infection. Zhuhai has also passed the peak of infection at the end of last month, and is now in a downward channel. The daily number of fever outpatient visits has shown obvious signs of falling back, but the critical care is still at a high plateau.” Luo Fuzhi, deputy director of the Zhuhai Health and Wellness Bureau, said at a news conference on January 10 on the prevention and control of the epidemic in Zhuhai.
In terms of good allocation of critical care supplies, Zhuhai has now expanded the number of critical care, respiratory and pediatric beds in hospitals above the second level in Zhuhai. At the same time, according to the actual situation of prevention and control and resources for treatment, a number of medical equipment such as monitors, ventilators and oxygen absorbers will be equipped in phases according to 40% physical reserve, 30% agreement reserve and 30% capacity reserve.
Huang Jian’en, deputy director of Zhuhai Municipal Market Supervision Bureau, said in reply to a question from a reporter of Southern Finance and Economics, according to incomplete statistics, as of January 9, the city’s relevant supply-protecting enterprises have put 7.75 million antipyretic drugs, 260,000 bottles of ibuprofen suspension and 4.58 million copies of antigen detection reagents in Zhuhai. At present, the retail pharmacies can basically meet the demand of the public for antipyretic drugs and antigen detection reagents; the stock of ibuprofen extended-release capsules/tablets in medical institutions can meet the clinical demand, and the demand for other cold and cough drugs is normal. In terms of drug supply, from January to June 2023, the market supervision department will carry out a special operation to stabilize the price and quality of epidemic-related drugs and medical supplies in the city.
Zhuhai antigen detection reagents monthly production reached 2.6 million copies
According to the mapping situation, Zhuhai Municipal Market Supervision Bureau, in conjunction with Zhuhai Medical Insurance Bureau and Zhuhai Health Bureau, has formulated an integrated mechanism of “production, supply, marketing and use” in advance to ensure supply.
Specifically, the Zhuhai Health Bureau, based on the number of people living in Zhuhai, estimated the development process of the epidemic, assessed the number of antipyretic drugs and antigen detection reagents that the city needed to basically meet before the peak of the epidemic, and the Zhuhai Market Supervision Bureau and Zhuhai ibuprofen, diclofenac sodium, loxoprofen sodium and antigen detection reagents manufacturers to negotiate the supply of Zhuhai City, the number and price of pharmaceuticals.
“The Zhuhai Municipal Medical Insurance Bureau monitored the data on the average daily consumption, inventory and demand of epidemic prevention drugs of 257 medical institutions that set up fever outpatient clinics, comprehensively considered the daily consumption, inventory and number of people receiving fever outpatient clinics in each medical institution, as well as the number of key drugs that could be supplied to medical institutions on that day, etc., and uniformly and reasonably allocated them according to the principle of prioritization to ensure that each The supply of drugs in each medical institution can meet the needs of the public for medical treatment.” Zhuhai City Medical Security Bureau Deputy Director Wang Tongxing said.
It is understood that at present, Zhuhai is included in the “Guangdong Province, the new crown virus infected with key drug supervision directory” a total of five enterprises, the production of new crown antigen test kits a total of one enterprise.
Huang Jianen said, in response to Zhuhai antipyretic drugs and antigen detection reagents production enterprises generally face staff off-duty due to illness, capacity shortages, Zhuhai Municipal Bureau of Market Supervision emergency from other enterprises in Zhuhai have surplus production capacity to second more than ten employees with relevant experience to assist some enterprises to supplement production capacity. At present, the production of antigen detection reagents in Zhuhai will be doubled to 2.6 million copies per month.
In order to reduce the pressure on the medical system, to effectively meet the needs of the public to purchase drugs, Zhuhai Municipal Bureau of Market Supervision in the country’s first to establish drugs, testing reagents and other epidemic prevention materials “fixed point split sales, real name registration, limited price limits” this flexible and innovative working mechanism and measures to benefit the public.
According to Huang Jian’en, the supply of medicine and equipment will be provided to medical institutions and retail pharmacies in the ratio of 3:7, and the number of supply will be dynamically adjusted according to the population distribution of each district; the emergency development of antipyretic drugs and antigen detection reagents sales registration WeChat small program will be registered in real names; more than 520 retail pharmacies in the city supply antipyretic drugs and 369 retail pharmacies supply new coronavirus antigen detection reagents, to achieve fixed point In addition, more than 520 retail pharmacies in the city supply antipyretic drugs and 369 retail pharmacies supply New Crown virus antigen testing reagents, realizing fixed-point, split-zero, limited and price-restricted sales, effectively alleviating the situation of “one drug is hard to find.
Soon online “new crown medical service platform”
At present, all 20 hospitals in Zhuhai at the second level and above have set up fever clinics to provide 24-hour services; 296 community health service centers (stations), town health centers and village health offices have set up fever clinics, and private hospitals, outpatient clinics and clinics receive patients with fever and respiratory symptoms under the premise of good protection. At the same time, make full use of the existing resources such as nucleic acid sampling huts and health check-up vehicles to adopt a fixed + mobile form and innovate the construction of mobile fever clinics to provide services for industrial parks, large enterprises and village houses.
Luo Fuzhi revealed that the “Zhuhai New Crown Medical Service Platform” will be launched in the near future. The platform will provide medical services such as online epidemic prevention and consultation, Internet consultation and drug purchase, vaccination appointment, fever clinic map inquiry, antigen reagent purchase and other service functions, so as to be able to respond to the public’s treatment needs in the face of the epidemic more quickly and conveniently, reduce the pressure of personnel gathering and offline medical security, and better realize the graded classification to resolve the demand for medical treatment.
“With the adjustment of the epidemic prevention and control policy, the new coronavirus infection in Zhuhai is still at the stage of having new cases daily. After human infection with new coronavirus, the immune system in the process of clearing the virus through cellular immunity and inflammatory response will lead to human respiratory tract congestion and edema, and even bleeding spots and other damage.” Huang Liqun, deputy director of the Zhuhai Center for Disease Control and Prevention, said that the human respiratory mucosa is very fragile at this time and has insufficient resistance to pathogens other than the new coronavirus. Therefore still need to do a good job of personal protection, the correct wear masks, etc., to avoid superimposed infection with other bacteria, viruses and other pathogens.
Huang Liqun calls for the current winter and spring respiratory infectious disease epidemic season, and the upcoming Chinese New Year festivities, frequent travel and mobility of people, increasing the risk of transmission of new coronavirus infection, influenza and other respiratory infectious diseases, should continue to do a good job of daily protective measures.
“This year’s Spring Festival compared with the previous two years, the situation task has changed significantly, and the willingness of passengers to travel has increased.” Zhou Yongwen, deputy director of Zhuhai Municipal Transport Bureau, said that according to the analysis of the study, it is expected that this year’s Spring Festival will carry about 2.75 million passengers, an increase of 86 percent over last year, reaching nearly 50 percent before the epidemic (2019). Among them, 200,000 passengers are expected to be transported by road, up 137% year-on-year; 200,000 passengers by waterway, up about 142% year-on-year; 1.6 million passengers by rail, up 86% year-on-year; and 750,000 passengers by Zhuhai Airport, up 65% year-on-year. The pre-holiday peak is expected to be relatively smooth, with the peak period appearing from January 17 to January 20, and the single-day passenger flow peak is expected to be 110,000, an increase of 81% year-on-year.
Average Rating